New pill targets rare cancer mutations in last-resort patients
NCT ID NCT04962867
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 20 times
Summary
This study tests an experimental drug called E7090 in people with advanced or recurrent solid tumors that have a specific genetic change (FGFR alteration). About 75 participants whose cancer has not responded to or is not eligible for standard treatments will receive the drug. The goal is to see if the drug can shrink tumors and control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR RECURRENT SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hokkaido University Hospital
RECRUITINGKita-Ku, Sapporo, Hokkaido, 060-8648, Japan
Contact
-
Kanagawa Cancer Center
RECRUITINGYokohama, Kanagawa, 241-8515, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kyoto University Hospital
RECRUITINGSakyo-ku, Kyoto, 606-8507, Japan
Contact
-
Kyushu University Hospital
RECRUITINGHigashi-Ku, Fukuoka, 812-8582, Japan
Contact
-
National Cancer Center Hospital
RECRUITINGChuo-ku, Tokyo, Japan, 104-0045, Japan
Contact
-
Okayama University Hospital
RECRUITINGOkayama, 700-8558, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Tohoku University Hospital
RECRUITINGAoba-ku, Sendai, Miyagi, 980-8574, Japan
Contact
Conditions
Explore the condition pages connected to this study.